HealthThe Promise of Lenacapavir: Breakthrough HIV Injection Faces Global Access Hurdles
A twice-yearly injectable drug offers remarkable efficacy in HIV prevention, but debates over pricing, generic access, and humanitarian distribution highlight stark global inequalities.
Al Jazeera English|October 1, 2026|1 